Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

As of April 30, 2025, there are 82 publicly listed companies in China engaged in the in vitro diagnostics (IVD) industry. Among them, 61 companies focus primarily on IVD, while 21 have IVD as part of their broader business portfolios.

On January 4th, the four-channel iPonatic nucleic acid detection analyzer of Sansure Biotech was certified by FDA. This is another global authority certification obtained after the approval of China NMPA and the European Union CE certification.

Researchers in China have identified dozens of causal relationships between blood metabolites and the microbes in the human gut.

Calibre Scientific said on Tuesday that it has acquired French life science reagent and instrument distributor AmpliTech.

Cure Genetics, a Chinese biotech startup that focuses on the treatment of cancers and genetic diseases, has secured $60 million in a Series B round of financing led by China-focused private equity (PE) firm Advantech Capital

Theranos founder Elizabeth Holmes has been convicted of defrauding investors after a months-long landmark trial in California.

The agency is expanding the use of a single booster of the Pfizer-BioNTech vaccine to children ages 12–15 and is shortening the time between primary vaccination and booster to at least five months.

Single-cell DNA sequencing firm Mission Bio said on Thursday that it has signed an agreement with China's SequMed to collaborate on services and the development of clinical applications.

On December 29, Shanghai Weihe Medical Laboratory Co., Ltd. was established with a registered capital of 1 million yuan. Equity penetration information shows that the company is indirectly wholly-owned by ByteDance.

Scientists at Scripps Research, University of Chicago and Icahn School of Medicine at Mount Sinai have identified a new Achilles’ heel of influenza virus, making progress in the quest for a universal flu vaccine.

Siemens Healthineers announces that the U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test,1, 2, 3 providing nationwide access to a new at-home or over-the-counter self-test as COVID-19 testing needs.